MARKET

BIAFW

BIAFW

bioAffinity Tech
NASDAQ
0.1518
0.0000
0.00%
Closed 09:30 11/19 EST
OPEN
0.1514
PREV CLOSE
0.1518
HIGH
0.1518
LOW
0.1514
VOLUME
54
TURNOVER
--
52 WEEK HIGH
0.9800
52 WEEK LOW
0.0501
MARKET CAP
--
P/E (TTM)
-0.0040
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at BIAFW last week (1109-1113)?
Weekly Report · 3d ago
Weekly Report: what happened at BIAFW last week (1102-1106)?
Weekly Report · 11/09 10:00
Weekly Report: what happened at BIAFW last week (1026-1030)?
Weekly Report · 11/02 10:00
Weekly Report: what happened at BIAFW last week (1019-1023)?
Weekly Report · 10/26 10:00
Weekly Report: what happened at BIAFW last week (1012-1016)?
Weekly Report · 10/19 10:00
bioAffinity Technologies to Present Positive Research Data in Development of Its New Test Measuring Asthma and COPD-Related Lung Inflammation and Drug-Related Receptors at CHEST 2026
Barchart · 10/13 07:00
Weekly Report: what happened at BIAFW last week (1005-1009)?
Weekly Report · 10/12 10:04
bioAffinity Technologies Reports Over 100% Growth in CyPath® Lung Sales Through Third Quarter 2026
Barchart · 10/06 08:19
More
About BIAFW
bioAffinity Technologies, Inc. is a biotechnology company focused on commercializing noninvasive tests for the detection of early-stage cancer and lung disease. The Company addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and broad-spectrum cancer treatment. Its segments include Diagnostic Research and Development (R&D) and Laboratory Services. Its Diagnostic R&D segment includes research and development and clinical development on diagnostic tests. Its Laboratory services include all the operations of Village Oaks and PPLS, in addition to sales and marketing of CyPath Lung from bioAffinity. Its first product, CyPath Lung, addresses the need for noninvasive detection of early-stage lung cancer. The CyPath Lung test enables physicians to more confidently identify patients who will likely benefit from timely intervention and more invasive follow-up procedures and those who are likely without lung cancer and should continue routine screening.

Webull offers bioAffinity Technologies Inc stock information, including NASDAQ: BIAFW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BIAFW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BIAFW stock methods without spending real money on the virtual paper trading platform.